4.3 Article

Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes

期刊

ONCOTARGET
卷 7, 期 46, 页码 74966-74978

出版社

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.11663

关键词

periostin; biomarkers; exosomes; metastatic; non-metastatic

资金

  1. Cancerfonden
  2. Radiumhemmets forskningsfonder
  3. Vetenskapsradet

向作者/读者索取更多资源

Breast cancer (BrCa) is the most frequent cancer type in women and a leading cause of cancer related deaths in the world. Despite the decrease in mortality due to better diagnostics and palliative care, there is a lack of prognostic markers of metastasis. Recently, the exploitation of liquid biopsies and in particular of the extracellular vesicles has shown promise in the identification of such prognostic markers. In this study we compared the proteomic content of exosomes derived from metastatic and non-metastatic human (MCF7 and MDA-MB-231) and mouse (67NR and 4T1) cell lines. We found significant differences not only in the amount of secreted exosomes but most importantly in the protein content of exosomes secreted from metastatic versus non-metastatic ones. We identified periostin as a protein that is enriched in exosomes secreted by metastatic cells and validated its presence in a pilot cohort of breast cancer patient samples with localized disease or lymph node (LN) metastasis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer Trial

Sara Mijwel, Kate A. Bolam, Jacob Gerrevall, Theodoros Foukakis, Yvonne Wengstrom, Helene Rundqvist

ONCOLOGIST (2020)

Article Multidisciplinary Sciences

Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology

Nina Olausson, Fariborz Mobarrez, Roman Zubarev, Alexey Chernobrovkin, Dorothea Rutishauser, Katarina Bremme, Eli Westerlund, Outi Hovatta, Hakan Wallen, Peter Henriksson

SCIENTIFIC REPORTS (2020)

Article Immunology

IL-16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity

David Krantz, Michael Mints, Malin Winerdal, Katrine Riklund, Dorothea Rutishauser, Roman Zubarev, Amir Ali Zirakhzadeh, Farhood Alamdari, Markus Johansson, Amir Sherif, Ola Winqvist

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2020)

Article Medicine, Research & Experimental

A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell death

Sophia Ceder, Sofi E. Eriksson, Emarndeena H. Cheteh, Swati Dawar, Mariana Corrales Benitez, Vladimir J. N. Bykov, Kenji M. Fujihara, Melodie Grandin, Xiaodun Li, Susanne Ramm, Corina Behrenbruch, Kaylene J. Simpson, Frederic Hollande, Lars Abrahmsen, Nicholas J. Clemons, Klas G. Wiman

Summary: The tumor suppressor gene TP53 is commonly mutated in cancer, and the compound APR-246 shows promise in targeting mutant p53 protein for cancer therapy. Combining APR-246 with inhibitors of efflux pump MRP1/ABCC1 results in synergistic tumor cell death, particularly in TP53 mutant cells, indicating the importance of redox homeostasis in response to mutant p53-targeted therapy.

EMBO MOLECULAR MEDICINE (2021)

Article Environmental Sciences

Challenges to Evidence Synthesis and Identification of Data Gaps in Human Biomonitoring

Ana Virgolino, Osvaldo Santos, Joana Costa, Monica Fialho, Ivo Iavicoli, Tiina Santonen, Hanna Tolonen, Evangelia Samoli, Klea Katsouyanni, Georgios Baltatzis, Flavia Ruggieri, Annalisa Abballe, Ida Petrovicova, Branislav Kolena, Miroslava Sidlovska, Carla Ancona, Ivan Erzen, Ovnair Sepai, Argelia Castano, Marike Kolossa-Gehring, Ulrike Fiddicke

Summary: The increasing number of human biomonitoring studies highlights the importance of harmonising procedures for data comparability. Techniques such as systematic literature reviews and data triangulation are being used to identify existing studies and data gaps.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Review Oncology

Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis

Caroline Boman, Ioannis Zerdes, Kira Martensson, Jonas Bergh, Theodoros Foukakis, Antonios Valachis, Alexios Matikas

Summary: The study found significant discordance in PD-L1 expression between primary and metastatic breast cancer, especially when PD-L1 status is assessed at metastatic sites. Pooled analysis of PD-L1 positivity rates in tumor cells and immune cells showed higher positivity in primary tumors compared to metastasis. Therefore, appropriate tissue sampling is crucial when selecting patients for immunotherapy.

CANCER TREATMENT REVIEWS (2021)

Article Cell Biology

Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells

Sophia Ceder, Sofi E. Eriksson, Ying Yu Liang, Emarndeena H. Cheteh, Si Min Zhang, Kenji M. Fujihara, Julie Bianchi, Vladimir J. N. Bykov, Lars Abrahmsen, Nicholas J. Clemons, Paer Nordlund, Sean G. Rudd, Klas G. Wiman

Summary: Asparaginase is a key treatment for acute lymphoblastic leukemia due to the asparagine auxotrophy of ALL blasts, but resistance can occur. TP53 mutations are rare in ALL but associated with poor therapy response, while APR-246 is being tested as a potential treatment for ALL. Combining asparaginase with APR-246 shows synergistic growth suppression in ALL cell lines, suggesting a new treatment strategy.

CELL DEATH & DISEASE (2021)

Article Oncology

Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer

Ioannis Zerdes, Vaia Karafousia, Artur Mezheyeuski, Maria Stogiannitsi, Raoul Kuiper, Pablo Moreno Ruiz, George Rassidakis, Jonas Bergh, Thomas Hatschek, Theodoros Foukakis, Alexios Matikas

Summary: The study reveals significant discordance in PD-L1 expression among various methods and between different areas of the same tumor, indicating the presence of spatial, intratumoral, and biological heterogeneity.

CANCERS (2021)

Article Medicine, Research & Experimental

lncRNA NORAD is consistently detected in breastmilk exosomes and its expression is downregulated in mothers of preterm infants

Niki Mourtzi, Tania Siahanidou, Margaritis Tsifintaris, Eirini Karamichali, Androniki Tasiopoulou, Amalia Sertedaki, Margarita Pesmatzoglou, Anastasia Kapetanaki, George Liosis, George Baltatzis, Dimitrios Vlachakis, George P. Chrousos, Antonis Giannakakis

Summary: This study found that lncRNAs in breast milk may play an important role in early human development, with generally higher levels of lncRNAs in the milk of mothers who gave birth at term compared to those who gave birth prematurely. The presence of lncRNAs in human breast milk could explain the consistent inability of researchers to fully 'humanize' animal milk.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Review Oncology

Dissecting Tumor-Immune Microenvironment in Breast Cancer at a Spatial and Multiplex Resolution

Evangelos Tzoras, Ioannis Zerdes, Nikos Tsiknakis, Georgios C. Manikis, Artur Mezheyeuski, Jonas Bergh, Alexios Matikas, Theodoros Foukakis

Summary: The evaluation of breast cancer immune microenvironment is important in clinical practice, but the spatiotemporal organization of the anti-breast cancer immune response is not fully explored yet. Multiplex in situ methods with spectral imaging can deconvolute the different elements of tumor immune microenvironment and provide valuable information for classification and biomarker discovery. These methods enable the simultaneous evaluation of multiple targets and characterization of spatial organization of the tumor immune microenvironment.

CANCERS (2022)

Article Oncology

Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study

Una Kjallquist, Balazs Acs, Sara Margolin, Emelie Karlsson, Luisa Edman Kessler, Scarlett Garcia Hernandez, Maria Ekholm, Christine Lundgren, Erik Olsson, Henrik Lindman, Theodoros Foukakis, Alexios Matikas, Johan Hartman

Summary: This study investigates the impact of gene-expression-based risk testing on patient management in hormone receptor positive early breast cancer. The study finds that routine pathology factors are poor predictors of the intrinsic subtype and recurrence risk score, while gene-expression-based risk combined with clinicopathological biomarkers can guide adjuvant chemotherapy decisions.

CANCERS (2022)

Article Oncology

ALK plus Anaplastic Large Cell Lymphoma (ALCL)-Derived Exosomes Carry ALK Signaling Proteins and Interact with Tumor Microenvironment

Dimitrios Chioureas, Janina Beck, George Baltatzis, Ioulia Vardaki, Pedro Fonseca, Nikolaos Tsesmetzis, Francisco Vega, Vasiliki Leventaki, Aristides G. Eliopoulos, Elias Drakos, George Z. Rassidakis, Theocharis Panaretakis

Summary: ALK+ anaplastic large cell lymphoma (ALK+ ALCL) is an aggressive non-Hodgkin lymphoma characterized by overexpression and activation of ALK kinase due to chromosomal translocations. This study demonstrates that ALK+ ALCL cells secrete exosomes containing critical components of ALK signaling which can be taken up by other cells, influencing tumor microenvironment and possibly contributing to treatment resistance. The interactions between ALK signaling and the microenvironment in ALK+ ALCL are not fully understood, but this research shows that exosome-mediated activation of stromal cells can alter the cytokine profile of the microenvironment, potentially impacting tumor aggressiveness and resistance to treatment.

CANCERS (2022)

Review Imaging Science & Photographic Technology

Harmonization Strategies in Multicenter MRI-Based Radiomics

Elisavet Stamoulou, Constantinos Spanakis, Georgios C. Manikis, Georgia Karanasiou, Grigoris Grigoriadis, Theodoros Foukakis, Manolis Tsiknakis, Dimitrios I. Fotiadis, Kostas Marias

Summary: Radiomics analysis is a powerful tool that extracts features from images to provide diagnostic and prognostic patient information. However, it is susceptible to bias and variation due to various factors. Effective harmonization methods are needed to address these issues.

JOURNAL OF IMAGING (2022)

Article Surgery

Axillary evaluation in ductal cancer in situ of the breast: challenging the diagnostic accuracy of clinical practice guidelines

Andreas Karakatsanis, Petros Charalampoudis, Lida Pistioli, Rosa Di Micco, Theodoros Foukakis, Antonios Valachis

Summary: Guidelines for upfront SLND in DCIS lack consistency and lead to significant practice variability. Accurate guidelines are needed to identify patients who would benefit from upfront SLND.

BRITISH JOURNAL OF SURGERY (2021)

Article Nutrition & Dietetics

Vitamin K intake and breast cancer incidence and death: results from a prospective cohort study

Kang Wang, Qianxue Wu, Zhuyue Li, Michael K. Reger, Yongfu Xiong, Guochao Zhong, Qing Li, Xiang Zhang, Hongyuan Li, Theodoros Foukakis, Tingxiu Xiang, Jianjun Zhang, Guosheng Ren

Summary: This study found that total menaquinones intake was associated with an increased risk of breast cancer and death from breast cancer in the general US population, whereas no significant associations were observed between total vitamin K and phylloquinone intake and breast cancer.

CLINICAL NUTRITION (2021)

暂无数据